Industry Expertise

Healthcare & Life Sciences

Healthcare organizations operate under some of the most complex regulatory frameworks in any industry. We provide audit and compliance services tailored to hospitals, health systems, pharma companies, and medical device manufacturers.

Industry Challenges

What Keeps Leadership Up at Night

Revenue recognition under ASC 606 for bundled service contracts, milestone-based licensing, and variable consideration

Regulatory compliance spanning HIPAA, Stark Law, Anti-Kickback Statute, and FDA reporting requirements

M&A activity requiring specialized diligence for physician practices, outpatient facilities, and pharma assets

Grant accounting and fund restrictions for research institutions and non-profit health systems

How FYNX Helps

Relevant Services for Healthcare & Life Sciences

Uncompromising Integrity

Audit & Assurance

We deliver audit and assurance services that go beyond compliance — providing stakeholders with the confidence that financial reporting reflects economic reality, not just technical adherence to standards.

Deal Excellence

Transaction Advisory

Our transaction advisory practice supports buyers, sellers, and investors through every stage of a deal — from initial screening to post-close integration — with a focus on protecting value and surfacing hidden risks.

Absolute Value

Valuation Services

We provide defensible, independent valuations for regulatory compliance, financial reporting, tax planning, and strategic decision-making — covering everything from early-stage equity to complex derivatives.

Capital Efficiency

Taxation Advisory

We help organizations structure their affairs to minimize tax leakage while maintaining full compliance — covering domestic and international tax planning, transfer pricing, and dispute resolution.

Related Case Studies

Finance Function Buildout for a PE-Backed Healthcare Platform

A private equity-backed healthcare services platform had completed three acquisitions in 18 months but was still operating each entity on separate accounting systems with no consolidated reporting. The PE sponsor required monthly consolidated financial packages and was planning a dividend recapitalization within 12 months.

✓ Consolidated three entities onto a single ERP platform in 10 weeks
✓ Reduced month-end close from 22 days to 5 days

Serving Healthcare & Life Sciences with depth and precision.

Discuss Your Requirements